Company / Free Cash Flow
Q32 Bio Inc. Free Cash Flow History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$67.8M
FY2025
5-year range
-$114.9M / -$18.7M
FY2021-FY2025
Trend
-262.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow changed -263% YoY in FY2025, a notable deviation from the 7-year average annual change of -263%.
Based on SEC 10-K filings.
-$68M in FY2025.
Improved from -$115M to -$68M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow decreased 262.9% year-over-year.
- Peak free cash flow was recorded in FY2018.
- Lowest free cash flow in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$67.8M | -262.9% |
| FY2024 | -$18.7M | +83.7% |
| FY2023 | -$114.9M | -2.5% |
| FY2022 | -$112.1M | -14.4% |
| FY2021 | -$98.1M | +13.4% |
| FY2020 | -$113.2M | -67.7% |
| FY2019 | -$67.5M | -1593.1% |
| FY2018 | $4.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026